ProCE Banner Activity

What Patients With BCC Need to Know About Therapy-Related Toxicities

Clinical Thought

Early recognition of treatment-related toxicities is essential for prompt management. In this commentary, Dr Anna Pavlick discusses educating patients and caregivers on the signs and symptoms of toxicities related to hedgehog pathway inhibitors and an immune checkpoint inhibitor approved for treatment of advanced basal cell carcinoma.

Released: November 29, 2022

Expiration: November 28, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Anna C. Pavlick

Anna C. Pavlick, MD, MBA

Professor of Medicine and Dermatology
Department of Medical Oncology
Director
Melanoma and Cutaneous Oncology Program
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by

Regeneron Pharmaceuticals, Inc

Sanofi

Additional Information

Program Medium

This program has been made available online.